Hyperlipidemia

The 2022 Cardiometabolic Health Congress will return in-person to Boston with the latest updates spanning all aspects of cardiometabolic health, including CVD, diabetes, kidney disease, lipid and lifestyle management and obesity.

BOSTON — PCSK9 inhibition before primary PCI for STEMI, on top of standard statin therapy, significantly lowered LDL at 6 weeks compared with sham control, according to the results of the EPIC-STEMI trial presented at TCT 2022.

The American College of Cardiology issued an expert consensus decision pathway to address new lipid-lowering agents and other developments since the release of the ACC/American Heart Association cholesterol guidelines in 2018.

Vupanorsen (Ionis) for reduction of non-HDL in patients with hyperlipidemia already on statin therapy.

Patients with aortic stenosis who received oral calcium supplementation had lower survival rates and were more likely to need aortic valve replacement than those who did not receive supplementation, according to recent data.

Exposure to occasional or frequent childhood abuse was associated with risk for incident type 2 diabetes and hyperlipidemia in adulthood, according to study findings published in the Journal of the American Heart Association.

The U.S. Preventive Services Task Force recommended statins for the primary prevention of CVD in patients aged 40 to 75 years with at least one CVD risk factor and 10% or greater 10-year risk for CVD.

Cardiologists, endocrinologists and primary care physicians will convene both virtually and in-person in National Harbor, Maryland, for the 2021 Cardiometabolic Health Congress.

A 55-year-old white man presented with the complaint of sudden onset central scotoma in both eyes for 1 month. The patient reported the condition slightly improved from the initial onset.

Diabetes and hyperlipidemia are both associated with granuloma annulare and may be risk factors for its development, according to a study.